imagine the scramble when the drug we started developing with Amring gets disclosed. A drug with US$400 million in yearly sales ( reportedly) . And why did Amring pull out of the deal? I hope it wasn’t to take what it’s learned to date and develop their own version. Because Amring have pulled out what stops them disclosing the drug to others? When something like this happens my suspicions are heightened as was joining ACR just a ploy to find out what we’re doing? For $300,000 thousand they get a heads up on the major seller.
ACR Price at posting:
7.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)